A Blue Cross Blue Shield initiative waiving copays for generic drugs and lowering them for other medicines improved adherence by 2 to 5 percent. Patients who hadn't been very good about sticking to their regimen in the past improved even more, says Joel Farley, PhD, the study's lead author.
The Coriell Institute for Medical Research is presenting Howard McLeod, PharmD, with one of its 2012 Coriell Personalized Medicine Research Awards. Coriell is known for its Personalized Medicine Collaborative research study, which examines the usefulness of genetic risk and pharmacogenomics in clinical decision making and health-care management.
In addition to exploring using mucus to stop pathogens, Lai will help develop a curriculum to teach middle and high school students about the health benefits of mucus.
Avinash Patil, MD, is one of the first fellows in a clinical pharmacology training program born of a collaboration between UNC and Duke. The program, which will expand to a nine fellows this summer, prepares clinician-scientists to become leaders and addresses critical problems in clinical pharmacology. Five positions in the expanded program will be NIH funded.
The 2012 Academic Unit University Diversity Award recognizes the School's efforts to advance diversity, which include a number of initiatives such as the LEAD program that introduce students from all backgrounds to the profession of pharmacy.
